Combination therapy for hepatitis C virus reinfection after orthoptic liver transplantation.
Israeli
E
E
Liver Unit, Division of Medicine, Jerusalem, Israel.
Galun
E
E
Eid
A
A
Ilan
Y
Y
Ashur
Y
Y
Jurim
O
O
Bishara
A
A
Safadi
R
R
D000998:Antiviral Agents / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005500:Follow-Up Studies; D019698:Hepatitis C, Chronic / Q000188:drug therapy*; D006801:Humans; D016898:Interferon-alpha / Q000627:therapeutic use*; D016031:Liver Transplantation; D011183:Postoperative Complications / Q000188:drug therapy; D012189:Retrospective Studies; D012254:Ribavirin / Q000627:therapeutic use*; D013997:Time Factors
D000998:Antiviral Agents; D016898:Interferon-alpha; D012254:Ribavirin